Lantheus Announces Collaboration to Support Prostate Cancer Clinical Development

0
9
Lantheus Holdings, Inc. announced a strategic collaboration with Novartis to include PYLARIFY® in prostate cancer clinical trials with Pluvicto™.
[Lantheus Holdings, Inc.]
Press Release